Sponsor Pipeline

Glenn J. Hanna Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-08 NCT05010629
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma		 Primary endpoint(s) modified
2026-08-08 NCT05010629
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma		 Trial arms changed: 1 -> 2
Active Trials by Phase
Phase 2
4
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06940180 Toripalimab With Chemotherapy for Sinus Cancer Sinonasal Cancer Recruiting
NCT06805617 A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland… Salivary Gland Cancer Recruiting
NCT06623110 Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease High-Risk Oral Precancerous Disease Recruiting
NCT05010629 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma Salivary Gland Cancer Active, Not Recruiting
Phase 1/2
NCT05774899 CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC Adenoid Cystic Carcinoma Recruiting
Disease Areas
Head & Neck Cancer (1)
Get alerts when Glenn J. Hanna's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free